Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
CN¥0.10 | 66.67% | ||
CN¥0.10 | 66.67% | ||
CN¥0.06 | 20% | ||
CN¥0.06 | 20% | ||
CN¥0.05 | 66.67% | ||
CN¥0.03 | -70% | ||
CN¥0.10 | 0% | ||
CN¥0.10 | 0% | ||
CN¥0.10 | 0% | ||
CN¥0.10 | 25% | ||
CN¥0.08 | -33.33% | ||
CN¥0.12 | -20% | ||
CN¥0.15 | 25% |
Shanghai Kaibao Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 1.50%.
- ISIN
- WKN
- -
- Symbol / Exchange
- / XSHE
- Value
- €0.85
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Shanghai Kaibao Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.10. For the next 12 months, Shanghai Kaibao Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.10. This corresponds to a dividend yield of approximately 1.50%.
- The dividend yield of Shanghai Kaibao Pharmaceutical Co Ltd Class A is currently 1.50%.
- Shanghai Kaibao Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in June.
- The next dividend for Shanghai Kaibao Pharmaceutical Co Ltd Class A is expected in June.
- Shanghai Kaibao Pharmaceutical Co Ltd Class A paid dividend every year within the last 10 years.
- Dividends of CN¥0.10 are expected for the next 12 months. This corresponds to a dividend yield of 1.50%.
- Shanghai Kaibao Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Shanghai Kaibao Pharmaceutical Co Ltd Class A was on 26 April 2010 in the ratio 1:1.
- To receive the last dividend of Shanghai Kaibao Pharmaceutical Co Ltd Class A on 19 June 2024 in the amount of CN¥0.10 you had to have the stock in your portfolio before the ex-day on 19 June 2024.
- The last dividend was paid on 19 June 2024.
- In 2022, dividends of CN¥0.05 were paid by Shanghai Kaibao Pharmaceutical Co Ltd Class A.
- Dividends from Shanghai Kaibao Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Shanghai Kaibao Pharmaceutical Co Ltd Class A is located in China.